SynthesisRMD open2023

Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study.

Céleste J T van der Togt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.